PT Kalbe Farma Tbk (PTKFF)
0.0524
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
PT Kalbe Farma Profit Margin (Quarterly) : 9.39% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.39% |
| March 31, 2026 | 10.88% |
| December 31, 2025 | 11.24% |
| September 30, 2025 | 7.48% |
| June 30, 2025 | 11.14% |
| March 31, 2025 | 12.64% |
| December 31, 2024 | 10.14% |
| September 30, 2024 | 7.15% |
| June 30, 2024 | 10.59% |
| March 31, 2024 | 11.81% |
| December 31, 2023 | 8.94% |
| September 30, 2023 | 7.54% |
| June 30, 2023 | 9.07% |
| March 31, 2023 | 10.85% |
| December 31, 2022 | 11.82% |
| September 30, 2022 | 11.79% |
| June 30, 2022 | 11.96% |
| March 31, 2022 | 12.15% |
| December 31, 2021 | 12.67% |
| September 30, 2021 | 12.08% |
| June 30, 2021 | 12.40% |
| March 31, 2021 | 12.03% |
| December 31, 2020 | 12.09% |
| September 30, 2020 | 12.09% |
| June 30, 2020 | 12.59% |
| Date | Value |
|---|---|
| March 31, 2020 | 11.68% |
| December 31, 2019 | 10.19% |
| September 30, 2019 | 11.82% |
| June 30, 2019 | 11.61% |
| March 31, 2019 | 11.25% |
| December 31, 2018 | 12.30% |
| September 30, 2018 | 11.33% |
| June 30, 2018 | 11.85% |
| March 31, 2018 | 11.92% |
| December 31, 2017 | 12.59% |
| September 30, 2017 | 11.43% |
| June 30, 2017 | 12.41% |
| March 31, 2017 | 12.17% |
| December 31, 2016 | 12.29% |
| September 30, 2016 | 11.70% |
| June 30, 2016 | 11.92% |
| March 31, 2016 | 12.67% |
| December 31, 2015 | 11.00% |
| September 30, 2015 | 10.20% |
| June 30, 2015 | 12.23% |
| March 31, 2015 | 12.65% |
| December 31, 2014 | 12.91% |
| September 30, 2014 | 11.58% |
| June 30, 2014 | 11.90% |
| March 31, 2014 | 12.44% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Avadel Pharmaceuticals Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.75% |
| Return on Assets | 11.89% |
| Return on Invested Capital | 14.43% |
| Gross Profit Margin (Quarterly) | 35.90% |
| Operating Margin (Quarterly) | 11.80% |
| Return on Net Operating Assets | 14.75% |